Overview

A Long-term Safety and Tolerability Study of USL261 in Patients With Seizure Clusters

Status:
Terminated
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the long-term safety and tolerability of USL261 in the treatment of seizure clusters.
Phase:
Phase 3
Details
Lead Sponsor:
UCB Biopharma S.P.R.L.
Upsher-Smith Laboratories
Treatments:
Midazolam